Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban plus low-dose intra-arterial urokinase for endovascular treatment of acute major ischemic stroke
2007-001996-13Phase 2Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Jun 2007
- Modality
- Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tirofiban and urokinase in ischemic stroke, sponsored by Azienda Ospedaliera Universitaria Senese. Primary endpoints: Change in NIHSS score at 24 hours, Change in NIHSS score at 7 days and 2 more. Started Jun 2007; status: completed.
02
Drugs
tirofibanurokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2007-001996-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001996-13.